Viking Therapeutics VKTX Operating Lease Right-of-Use Assets in Other Assets
Operating Lease Right-of-Use Assets in Other Assets at other companies
Other financials
Where this comes from
Reported directly by Viking Therapeutics in its filing.
Tagged under the XBRL concept us-gaap:OperatingLeaseRightOfUseAsset.
The official record: Viking Therapeutics’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →
Ask your AI about Viking Therapeutics's operating lease right-of-use assets in other assets.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Viking Therapeutics's operating lease right-of-use assets in other assets?
- Viking Therapeutics (VKTX) reported operating lease right-of-use assets in other assets of $0 in Q1 2026.
- How has Viking Therapeutics's operating lease right-of-use assets in other assets changed year-over-year?
- Viking Therapeutics's operating lease right-of-use assets in other assets decreased by 100.0% year-over-year, from $892K to $0.
- What is the long-term trend for Viking Therapeutics's operating lease right-of-use assets in other assets?
- Over 5 years (2020 to 2025), Viking Therapeutics's operating lease right-of-use assets in other assets has grown at a -23.3% compound annual growth rate (CAGR), from $321K to $85K.